M. ROBBA

3.1k total citations · 1 hit paper
213 papers, 2.3k citations indexed

About

M. ROBBA is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, M. ROBBA has authored 213 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Organic Chemistry, 55 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in M. ROBBA's work include Synthesis and Characterization of Heterocyclic Compounds (59 papers), Synthesis and Reactivity of Heterocycles (58 papers) and Synthesis and Biological Evaluation (52 papers). M. ROBBA is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (59 papers), Synthesis and Reactivity of Heterocycles (58 papers) and Synthesis and Biological Evaluation (52 papers). M. ROBBA collaborates with scholars based in France, Egypt and Italy. M. ROBBA's co-authors include Sylvain Rault, Jean‐Charles Lancelot, H. Pollard, M. Garbarg, Walter Schunack, J.M. Arrang, J.C. Schwartz, Jeanne‐Marie Lecomte, S. Rault and Patrick Dallemagne and has published in prestigious journals such as Nature, Biochemical Journal and Chemosphere.

In The Last Decade

M. ROBBA

201 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Highly potent and selective ligands for histamine H3-receptors

1987 767 citations J.M. Arrang, M. Garbarg et al. profile →

Peers

Countries citing papers authored by M. ROBBA

Since Specialization

Citations

This map shows the geographic impact of M. ROBBA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. ROBBA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. ROBBA more than expected).

Fields of papers citing papers by M. ROBBA

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. ROBBA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. ROBBA. The network helps show where M. ROBBA may publish in the future.

Co-authorship network of co-authors of M. ROBBA

This figure shows the co-authorship network connecting the top 25 collaborators of M. ROBBA. A scholar is included among the top collaborators of M. ROBBA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. ROBBA. M. ROBBA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First Synthesis of N-(4-Fluorophenyl)-5-(4-fluorophenyl)-2-(4-hydroxybenzyl)pentanamide, a New Potential Cholesterol Absorption Inhibitor 2000 ·Pharmacy and Pharmacology Communications ·Jean Guillon, Silvia Stiebing, M. ROBBA	1
2	In Vivo Nitric Oxide Synthase Inhibitors Can Be Deprived of ThisActivity: Unexpected Influence of the Tetrachloroplatinate(II) Counteranion.Crystal Structures of Bis(S‐Methyl‐Isothiouronium)‐N,N′‐Bis(3‐Guanidinopropyl)Piperazinium and HexamidiniumTetrachloroplatinates(II) Salts 1998 ·Metal-Based Drugs ·Georges Morgant, Β. Viossat, M Roch-Arveiller, P. Prognon, Jean‐Paul Giroud, Jean‐Charles Lancelot, M. ROBBA, (unknown)	3
3	Synthesis, Crystal Structure and Interaction With DNA of N,N′‐(Butane‐1,4‐Diyl)Bis(Guanidinium) Tetrachloroplatinate (II) 1998 ·Metal-Based Drugs ·Christian Bailly, Β. Viossat, (unknown), Georges Morgant, (unknown), (unknown), M. ROBBA, Nguyen Huy Dung	2
4	Synthesis and Evaluation of the CNS Activity of New 4-Alkoxyphenylimidazolidin-2-ones. 1998 ·Chemical and Pharmaceutical Bulletin ·Jean Guillon, (unknown), O. Renault, Michel Boulouard, Patrick Dallemagne, Sylvain Rault, M. ROBBA	2
5	Synthesis and Cytotoxic Activity against L1210 Leukemia of New Aminocyclopenta(c)thiophenones. 1994 ·Chemical and Pharmaceutical Bulletin ·(unknown), (unknown), Patrick Dallemagne, Franck Carreiras, Pascal Gauduchon, Sylvain Rault, M. ROBBA	8
6	Mass spectral study of chlorofluorocarbons (CFCs) and potential alternatives (HCFCs and HFCs) 1994 ·Ecotoxicology and Environmental Safety ·(unknown), (unknown), S. Rault, M. ROBBA	5
7	Mutagenicity of nitro- and amino-substituted carbazoles in Salmonella typhimurium. 1993 ·Mutation Research/Genetic Toxicology ·Valérie André, (unknown), (unknown), Pascal Gauduchon, (unknown), Jean‐Charles Lancelot, (unknown), (unknown), S. Rault, M. ROBBA	14
8	Synthèse et étude de l'activité cytotoxique in vitro et antitumorale in vivo de nouvelles pyrrolo[2,1-c][1,4]benzodiazépines: partie I 1992 ·European Journal of Medicinal Chemistry ·(unknown), Esther Caballero, S. Rault, M. ROBBA	10
9	Comparative molecular field analysis of CCK-A antagonists using field-fit as an alignment technique. A convenient guide to design new CCK-A ligands 1992 ·Journal of Computer-Aided Molecular Design ·Sylvain Rault, Ronan Bureau, (unknown), M. ROBBA	11
10	The Third Histamine Receptor 1989 ·International Archives of Allergy and Immunology ·J.M. Arrang, M. Garbarg, (unknown), J Lecomte, H. Pollard, M. ROBBA, Walter Schunack, J.C. Schwartz	11
11	Effect of cetiedil analogs on acetylcholine and choline fluxes in synaptosomes and vesicles 1989 ·European Journal of Pharmacology ·(unknown), Marie‐Françoise Diebler, M. ROBBA, (unknown), B. Lesbats, Maurice Israël	13
12	Synthesis and evaluation of antileukemic activity of 5-thienyl- or 5-(2-furyl)-2,3-dihydro-6,7-bis(hydroxymethyl)-1H-pyrrolizine bis(alkylcarbamates) and derivatives 1989 ·Journal of Medicinal Chemistry ·(unknown), (unknown), M. ROBBA, E. Chenu, G Mathé	21
13	Synthesis of 4-Aminothieno[2,3-c]pyrid-7-one from 4-Aminocyclopenta[b]thiophen-6-one 1988 ·Heterocycles ·M. ROBBA, Patrick Dallemagne, (unknown), (unknown)	2
14	Highly Potent and Selective Ligands for a New Class H3 of Histamine Receptor 1988 ·Investigative Radiology ·J.M. Arrang, M. Garbarg, Jean‐Charles Lancelot, J Lecomte, H. Pollard, M. ROBBA, Walter Schunack, Joseph E. Schwartz	11
15	Un Agent Trichomonacide: Le (Thenoyl-2')-amino-2 nitro-5 thiazole C_8H_5O_3N_3S_2. II. Structure Cristalline et Moleculaire d'une Nouvelle Variete Monoclinique Solvatee par le Dimethylformamide(Medicinal Chemistry,Chemical) 1987 ·Chemical and Pharmaceutical Bulletin ·Β. Viossat, (unknown), Jean‐Charles Lancelot, Françis Robert, M. ROBBA	2
16	Pyrrolo (1',2':1,2) pyrazino (6,5-c) and (5,6-b) carbazoles. Synthesis and study of nuclear magnetic resonance spectrum. 1984 ·Chemical and Pharmaceutical Bulletin ·Jean‐Charles Lancelot, (unknown), Sylvain Rault, Nguyen Huy Dung, M. ROBBA	7
17	Pyrrolo[1,2‐a]thiéno[2,3‐e]pyrazine. Etude chimique de la dihydro‐4,5 oxo‐5 pyrrolo[1,2‐a]thiéno[2,3‐e]pyrazine 1983 ·Journal of Heterocyclic Chemistry ·(unknown), Jean‐Charles Lancelot, Sylvain Rault, M. ROBBA	6
18	1,4‐ジアゼピン類の新しい簡易合成法 6‐アルコキシ‐5,6‐ジヒドロ‐4H‐ピロロ〔1,2‐a〕チエノ〔3,2‐f〕‐1,4‐ジアゼピン‐4‐オン 1979 ·Heterocycles ·S. Rault, (unknown), M. ROBBA	11
19	as‐Triazino[4,5‐α] indoles. III. Etude des substitutions électrophiles des triazinoindolones 1978 ·Journal of Heterocyclic Chemistry ·M. ROBBA, Daniel Maume, Jean‐Charles Lancelot	11
20	Thiénopyrimidines—II 1971 ·Tetrahedron ·M. ROBBA, (unknown), (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact